CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 217 filers reported holding CHEMOCENTRYX INC in Q3 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $77,000 | +285.0% | 430 | -45.8% | 0.00% | – |
| Q2 2022 | $20,000 | 0.0% | 794 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -31.0% | 794 | 0.0% | 0.00% | – |
| Q4 2021 | $29,000 | +26.1% | 794 | -41.5% | 0.00% | – |
| Q3 2021 | $23,000 | +27.8% | 1,357 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | -100.0% | 1,357 | -99.9% | 0.00% | -100.0% |
| Q1 2021 | $65,778,000 | +4.3% | 1,283,708 | +26.1% | 0.09% | +1.1% |
| Q4 2020 | $63,044,000 | +33.8% | 1,018,155 | +18.4% | 0.09% | +15.0% |
| Q3 2020 | $47,133,000 | +69.2% | 860,092 | +77.7% | 0.08% | +66.7% |
| Q2 2020 | $27,851,000 | +79.5% | 484,038 | +25.4% | 0.05% | +50.0% |
| Q1 2020 | $15,513,000 | +37736.6% | 386,076 | +10059.9% | 0.03% | – |
| Q4 2018 | $41,000 | -30.5% | 3,800 | -19.1% | 0.00% | – |
| Q3 2018 | $59,000 | -54.6% | 4,700 | -52.5% | 0.00% | – |
| Q2 2018 | $130,000 | +1344.4% | 9,900 | +560.0% | 0.00% | – |
| Q4 2017 | $9,000 | -85.9% | 1,500 | -82.6% | 0.00% | – |
| Q3 2017 | $64,000 | – | 8,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |